清道夫受体A联合抗环瓜氨酸肽抗体诊断类风湿关节炎
本研究通过预试验和大规模多中心研究评估清道夫受体A(SR-A)联合其他生物标志物诊断类风湿关节炎(RA)的价值,共纳入三个队列1129人。结果显示SR-A与抗CCP抗体双联组合为RA诊断最优方法,使抗CCP抗体灵敏度提高13%(87% vs 74%)而保持特异度90%;在早期RA中灵敏度提高7%(79% vs 72%)而保持特异度94%。
要点
- SR-A与抗CCP抗体双联组合为RA诊断最优方法,灵敏度87% vs 抗CCP单用74%,特异度90%。
- 早期RA中该双联组合灵敏度79% vs 抗CCP单用72%,特异度94%。
- 该双联组合与RA患者ESR、IgM及自身抗体相关。
核心结论
- SR-A与抗CCP抗体双联组合可能改善RA的早期诊断,从而改善预后并降低死亡率。
研究设计与样本
- 研究先通过预试验揭示SR-A联合其他生物标志物诊断RA的性能,再通过大规模多中心研究进一步阐明。
- 共纳入来自三个队列的1129人,包括RA患者、健康对照和其他常见风湿病患者。
- 诊断性能通过协变量调整的受试者工作特征曲线、灵敏度、特异度和临床关联进行评估。
主要发现
- 大规模多中心分析显示,SR-A与抗CCP抗体双联组合为RA诊断的最优方法,使抗CCP抗体灵敏度提高13%(87% vs 74%),同时保持特异度90%。
- 在早期RA患者中,SR-A与抗CCP抗体双联组合也显示出有前景的诊断价值,使抗CCP抗体灵敏度提高7%(79% vs 72%),同时保持特异度94%。
- SR-A与抗CCP抗体双联组合与RA患者的ESR、IgM及自身抗体相关,进一步揭示其临床意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The routine biomarkers for RA, including anti-CCP, RF, IgM, ESR and CRP, have limited sensitivity and specificity. Scavenger receptor-A (SR-A) is a novel RA biomarker identified recently by our group, especially for seronegative RA. Here, we performed a large-scale, multicentre study to further assess the diagnostic value of SR-A in combination with other biomarkers for RA. METHODS: The performance of SR-A in combination with other biomarkers for RA diagnosis was first revealed by a pilot study, and was further elucidated by a large-scale, multicentre study. A total of 1129 individuals from three cohorts were recruited in the study, including RA patients, healthy controls and patients with other common rheumatic diseases. Diagnostic properties were evaluated by the covariate-adjusted receiver operating characteristic curve, sensitivity, specificity and clinical association. RESULTS: Large-scale multicentre analysis showed that SR-A and anti-CCP dual combination was the optimal method for RA diagnosis, increasing the sensitivity of anti-CCP by 13% (87% vs 74%) while maintaining a specificity of 90%. In early RA patients, SR-A and anti-CCP dual combination also showed promising diagnostic value, increasing the sensitivity of anti-CCP by 7% (79% vs 72%) while maintaining a specificity of 94%. Moreover, SR-A and anti-CCP dual combination was correlated with ESR, IgM and autoantibodies of RA patients, further revealing its clinical significance. CONCLUSION: SR-A and anti-CCP dual combination could potentially improve early diagnosis of RA, thus improving the prognosis and reducing mortality.
引用
- Wei C, Wang P, Zhang J, et al. Combination of scavenger receptor-A with anti-cyclic citrullinated peptide antibody for the diagnosis of rheumatoid arthritis. Rheumatology (Oxford). 2025. PMID: 38781519. doi:10.1093/rheumatology/keae297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。